Timothy Rearden

Associate Professor of Medicine

    • 125 Citations
    1982 …2010

    Research output per year

    If you made any changes in Pure these will be visible here soon.

    Personal profile

    Research interests

    Lung cancer, breast cancer, gastrointestinal cancer and lymphoma

    Areas of Clinical Interest

    Lung cancer, breast cancer, gastrointestinal cancer and lymphoma

    Fingerprint Dive into the research topics where Timothy Rearden is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    Research Output

    • 125 Citations
    • 8 Article

    Comparison of darbepoetin alfa dosed weekly (QW) vs. extended dosing schedule (EDS) in the treatment of anemia in patients receiving multicycle chemotherapy in a randomized, phase 2, open-label trial

    Schwartzberg, L., Burkes, R., Mirtsching, B., Rearden, T., Silberstein, P., Yee, L., Inamoto, A. & Lillie, T., Oct 25 2010, In : BMC Cancer. 10, 1, 581.

    Research output: Contribution to journalArticle

    Open Access
  • 5 Scopus citations

    A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia

    Schwartzberg, L., Rearden, T., Yee, L., Mirtsching, B., Charu, V., Lam, H., Lillie, T., Burkes, R. & Silberstein, P., Apr 1 2007, In : Journal of Supportive Oncology. 5, 4 SUPPL. 2, p. 22-23 2 p.

    Research output: Contribution to journalArticle

    1 Scopus citations

    A randomized, open-label, multicenter trial of immediate versus delayed intervention with darbepoetin alfa for chemotherapy-induced anemia

    Charu, V., Saidman, B., Ben-Jacob, A., Justice, G. R., Maniam, A. S., Tomita, D., Rossi, G., Rearden, T. & Glaspy, J., Oct 1 2007, In : Oncologist. 12, 10, p. 1253-1263 11 p.

    Research output: Contribution to journalArticle

    Open Access
  • 14 Scopus citations

    Improvements in fatigue are associated with early treatment with darbepoetin alfa every 3 weeks in anemic patients receiving chemotherapy

    Charu, V., Saidman, B., Ben-Jacob, A., Justice, G. R., Maniam, A. S., Rearden, T., Tomita, D. & Rossi, G., Mar 1 2005, In : Journal of Supportive Oncology. 3, 2 SUPPL. 1, p. 14-15 2 p.

    Research output: Contribution to journalArticle

    1 Scopus citations

    Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer

    Adkins, D., Brown, R., Trinkaus, K., Maziarz, R., Luedke, S., Freytes, C., Needles, B., Wienski, D., Fracasso, P., Pluard, T., Moriconi, W., Ryan, T., Hoelzer, K., Safdar, S., Rearden, T., Rodriguez, G., Khoury, H., Vij, R. & DiPersio, J., Jul 1 1999, In : Journal of Clinical Oncology. 17, 7, p. 2006-2014 9 p.

    Research output: Contribution to journalArticle

  • 41 Scopus citations